Advances in Clinical and Experimental Medicine

Adv Clin Exp Med
Impact Factor (IF) – 1.514
Index Copernicus (ICV 2018) – 157.72
MNiSW – 40
Average rejection rate – 84.38%
ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download PDF

Advances in Clinical and Experimental Medicine

2013, vol. 22, nr 5, September-October, p. 621–627

Publication type: original article

Language: English

Protective Effects of Melatonin and β-d-Glucan Against Liver Injury in Rats – a Comparative Study

Działanie ochronne melatoniny i β-d-glukanu w uszkodzeniach wątroby u szczurów – studium porównawcze

Mustafa Said Aydogan1,A,C,D, Mehmet Ali Erdogan1,D,E, Aladdin Polat2,B, Aytac Yücel1,E, Ulkü Ozgül1,E, Hakan Parlakpinar3,B, Zeynep Rumeysa Duran2,B, Azibe Yildiz4,C, Mahmut Durmus1,D

1 Department of Anesthesiology and Reanimation

2 Department of Physiology

3 Department of Pharmacology

4 Department of Histology, Inonu University, Faculty of Medicine, Malatya, Turkey


Objectives. The aim of this study was to investigate the possible protective effects of melatonin and β-d-glucan against ischemia-reperfusion (IR) injury in rats.
Material and Methods. Forty rats were randomly divided into 5 groups, each consisting of 8 animals, as follows. Sham group [S], IR group [C], IR + β-Glucan group [β], IR + melatonin group [MLT], IR + melatonin + β-Glucan group [MLT + β]. The rats in the C, β, MLT and MLT + β groups were subjected to IR for 60 min each. Melatonin (10 mg∙kg–1) was intraperitoneally injected for a single dose 30 min before IR. β-Glucan (50 mg∙kg–1∙day–1) was orally administered for 10 days to rats. All of the rats were killed on day 11, and histological changes in the liver and tissue levels of oxidants and antioxidants were evaluated.
Results. Malondialdehyde [MDA] level were significantly higher in the C group compared to the S group (p = 0.007). MDA level were significantly higher in the β group compared to the MLT and MLT + β groups (p =0.007). Tissue antioxidant markers (superoxide dismut ase [SOD], glutathione-peroxidase [GPx], and catalase [CAT]) were significantly lower in the C group than the S group (p < 0.05). SOD levels were simply not significant in the β group compared to the MLT and MLT + β groups. CAT and GPx activities were significantly higher in the β group compared to the MLT and MLT + β groups (p = 0.004).The histological damage ameliorated in β, MLT and MLT + β groups compared to C group.
Conclusion. Our results suggest that melatonin and β-glucan combination pretreatment suppressed oxidative stress and increased antioxidant levels in an experimental rat model of liver IR injury.

Key words

liver, ischemia reperfusion injury, melatonin, β-glucan, oxidative stress.

Słowa kluczowe

wątroba, szkodzenie niedokrwienno-reperfuzyjne, melatonina, β-glukan, stres oksydacyjny.

References (33)

  1. Clavien PA, Selzner M, Rüdiger HA, Graf R, Kadry Z, Rousson V, Jochum W: A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003, 238, 843–852.
  2. Dogan S, Aslan M: Hepatic ischemia-reperfusion injury and therapeutic strategies to alleviate cellular damage. Hepatol Res 2011, 41, 103–117.
  3. Wang J, Kan Q, Li J, Zhang X, Qi Y: Effect of neferine on liverischemia-reperfusioninjury in rats. Transplant Proc 2011, 43, 2536–2539.
  4. Toklu HZ, Sener G, Jahovic N, Uslu B, Arbak S, Yegen BC: Beta-glucan protects against burn-induced oxidative organ damage in rats. IntImmunopharmacol 2006, 6, 156–169.
  5. Babincova M, Bacova Z, Machova E, Kogan G: Antioxidant properties of carboxymethylglucan: comparative analysis. J Med Food 2002, 5, 79–83.
  6. Kang JW, Koh EJ, Lee SM: Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll-like receptor signaling pathway. J Pineal Res 2011, 50, 403–411.
  7. Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martín V, Reiter RJ: Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004, 36, 1–9.
  8. Klune JR, Tsung A: Molecular biology of liver ischemia/repefusion injury: established mechanisms and recent advancements. Surg Clin North Am 2010, 90, 665–677.
  9. Czubkowski P, Socha P, Pawlowska J: Current status of oxidative stress in pediatric liver transplantation. Pediatr Transplant 2010, 14, 169–177.
  10. Schindler G, Kincius M, Liang R, Backhaus J, Zorn M, Flechtenmacher C, Gebhard MM, Büchler MW, Schemmer P: Fundamental efforts toward the development of a therapeutic cocktail with a manifold ameliorative effect on hepatic ischemia/reperfusion injury. Microcirculation 2009, 22, 1–10.
  11. Toklu HZ, Sehirli AO, Velioğlu Oğünç A, Cetinel S, Sener G: Acetaminophen-induced toxicity is prevented by beta-d-glucan treatment in mice. Eur J Pharmacol 2006, 14, 133–140.
  12. Sener G, Sehirli AO, Ayanoglu Dülger G: Protective effects of melatonin, vitamin E and N-acetylcysteine against acetaminophen toxicity in mice: a comparative study. J Pineal Res 2003, 35, 61–68.
  13. Sun Y, Oberley L, Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem 1988, 34, 497–500.
  14. Aebi H: Catalase. [In:] Methods of enzymatic analysis. Ed.: Bergmeyer HU. Academic Press, New York 1974. 673–677.
  15. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70, 158–170.
  16. Mihara M, Uchiyama M: Determination of malonaldehyde precursor in tissues by tiobarbituric acid test. Anal Biochem 1978, 86, 271–278.
  17. Lowry O, Rosenbraugh N, Farr L, Rondall R: Protein measurement with the folin-phenol reagent. J Biol Chem 1951, 193, 265–275.
  18. Hasselgren PO: Prevention and treatment of ischemia of the liver. Surg Gynecol Obstet 1987, 164, 187–196.
  19. Sakon M, Ariyoshi H, Umeshita K, Monden M: Ischemia reperfusion injury of the liver with special reference to calcium dependent mechanisms. Surg Today 2002, 32, 1–12.
  20. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A: Biomarkers of oxidative damage in human disease. Clin Chem 2006, 52, 601–623.
  21. García JJ, Reiter RJ, Guerrero JM, Escames G, Yu BP, Oh CS, Muñoz-Hoyos A:Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. Febs Lett 1997, 408, 297–300
  22. Budziński G, Suszka-Świtek A, Caban A, Oczkowicz G, Heitzman M, Wystrychowski W, Dolińska B, Ryszka F, Cierpka L: Evaluation of cysteine effect on redox potential of porcine liver preserved by simple hypothermia. Transplant Proc. 2011, 43, 2897–2899.
  23. Deleve LD, Kaplowitz N: Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 1991, 52, 287–305.
  24. Noyan T, Kömüroğlu U, Bayram I, Sekeroğlu MR: Comparison of the effects of melatonin and pentoxifylline on carbon tetrachloride-induced liver toxicity in mice. Cell Biol Toxicol 2006, 22, 381–391.
  25. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Czarnocki Z: Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 2003, 50, 1129–1146.
  26. Reiter JR, Tan DX, Sainz RM, Mayo JC, Lopez-Burillo S: Melatonin: in reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 2002, 54, 1299–1321.
  27. Galecka E, Jacewicz R, Mrowicka M, Florkowski A, Gałecki P: Antioxidative enzymes-structure, properties, functions. Pol Merk Lek 2008, 25, 266–268.
  28. Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, Hashida M: Prevention of neutrophil – mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther 2001, 298, 894–899.
  29. Koolj A, Schiller HJ, Schlins M, Van Noorden CJ, Frederiks WM: Conversion of xanthine dehydrogenase into xanthine oxidase in rat liver and plasma at the onset of reperfusion after ischemia. Hepatology 1994, 19, 1488–1495.
  30. McKillen MN: Respiratory burst oxidase of the neutrophil. Biochem Soc Trans 1990, 19, 49–78.
  31. Yabe Y, Koyama Y, Nishikawa M, Takakura Y, Hashida M: Hepatocyte-specific distribution of catalase and its inhibitory effect on hepatic ischemia/reperfusion injury in mice. Free Rad Res 1999, 30, 265–274.
  32. Ozansoy G, Akin B, Aktan F, Karasu C: Short-term gemfibrozil treatment reverses lipid profile and peroxidation but does not alter blood glucose and tissue antioxidant enzymes in chronically diabetic rats. Mol Cell Biochem 2001, 216, 59–63.
  33. Ceylan A, Karasu C, Aktan F, Güven C, Can B, Ozansoy G: Effects of simvastatin treatment on oxidant/antioxidant state and ultrastructure of diabetic rat myocardium. Gen Physiol Biophys 2003, 22, 535–547.